Agreement on Major Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemotherapy

INTRODUCTION: We have suggested that major pathological response (MPR) could serve as a surrogate endpoint for survival and provide rapid means of comparing different neoadjuvant treatment regimens. In here, we confirm that MPR is predictive of long-term overall survival (OS) in patients with NSCLC...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Clin Lung Cancer
Main Authors: Weissferdt, Annikka, Pataer, Apar, Vaporciyan, Ara A., Correa, Arlene M., Sepesi, Boris, Moran, Cesar A., Wistuba, Ignacio I., Roth, Jack A., Shewale, Jitesh Baban, Heymach, John V., Kalhor, Neda, Cascone, Tina, Hofstetter, Wayne L., Lee, J. Jack, Swisher, Stephen G.
Formáid: Artigo
Teanga:Inglês
Foilsithe: 2020
Ábhair:
Article
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7305995/
https://ncbi.nlm.nih.gov/pubmed/32279936
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cllc.2019.11.003
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla